[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Impact of Body Mass Index on Hospitalization Outcomes in Patients With Acute Ischemic Stroke",
    "section": "",
    "text": "Reference Papers:\n\nPersaud et al.2019\nSreenivasan et al. 2022\n\nStudy Objective: Examine the impact of body mass index (BMI) on outcomes among inpatient admissions with acute ischemic stroke (AIS).\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with a principal diagnosis of AIS.\nBMI Categories:\n\nUnderweight: BMI ≤19.9 kg/m²\nNormal Weight: BMI 20.0 to 24.9 kg/m²\nOverweight: BMI 25.0 to 29.9 kg/m²\nClass I Obesity: BMI 30.0 to 34.9 kg/m²\nClass II Obesity: BMI 35.0 to 39.9 kg/m²\nClass III Obesity: BMI ≥40.0 kg/m²\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nStatistical Analysis: Multiple logistic and linear regression to determine the independent association of BMI categories with in-hospital mortality and length of stay, respectively, adjusted for:\n\nDemographics: Age, gender, race\nMedical History: Previous coronary artery bypass graft, myocardial infarction, percutaneous coronary intervention\nComorbidities: Charlson comorbidity index, atrial fibrillation, heart failure, peripheral vascular disease, dementia, tobacco use disorder, chronic obstructive pulmonary disease, valvular heart disease, liver disease, diabetes mellitus, hypertension, chronic kidney disease, hyperlipidemia, and any cancer.\nMedical Interventions: Administration of IV tissue-type plasminogen activator and utilization of thrombectomy\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Impact of Body Mass Index on Hospitalization Outcomes in Patients With Acute Ischemic Stroke",
    "section": "",
    "text": "Reference Papers:\n\nPersaud et al.2019\nSreenivasan et al. 2022\n\nStudy Objective: Examine the impact of body mass index (BMI) on outcomes among inpatient admissions with acute ischemic stroke (AIS).\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with a principal diagnosis of AIS.\nBMI Categories:\n\nUnderweight: BMI ≤19.9 kg/m²\nNormal Weight: BMI 20.0 to 24.9 kg/m²\nOverweight: BMI 25.0 to 29.9 kg/m²\nClass I Obesity: BMI 30.0 to 34.9 kg/m²\nClass II Obesity: BMI 35.0 to 39.9 kg/m²\nClass III Obesity: BMI ≥40.0 kg/m²\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nStatistical Analysis: Multiple logistic and linear regression to determine the independent association of BMI categories with in-hospital mortality and length of stay, respectively, adjusted for:\n\nDemographics: Age, gender, race\nMedical History: Previous coronary artery bypass graft, myocardial infarction, percutaneous coronary intervention\nComorbidities: Charlson comorbidity index, atrial fibrillation, heart failure, peripheral vascular disease, dementia, tobacco use disorder, chronic obstructive pulmonary disease, valvular heart disease, liver disease, diabetes mellitus, hypertension, chronic kidney disease, hyperlipidemia, and any cancer.\nMedical Interventions: Administration of IV tissue-type plasminogen activator and utilization of thrombectomy\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#baseline-characterstics",
    "href": "quarto/index.html#baseline-characterstics",
    "title": "Impact of Body Mass Index on Hospitalization Outcomes in Patients With Acute Ischemic Stroke",
    "section": "Baseline Characterstics:",
    "text": "Baseline Characterstics:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nNormal weight (BMI 20.0-24.9kg/m²) N = 16,4301\nOverall N = 267,6501\nClass I obesity (BMI 30.0-34.9kg/m²) N = 68,7701\nClass II obesity (BMI 35.0-39.9kg/m²) N = 52,8201\nClass III obesity (BMI ≥40.0kg/m²) N = 72,7001\nOverweight (BMI 25.0-29.9kg/m²) N = 25,8201\nUnderweight (BMI ≤19.9kg/m²) N = 31,1101\np-value2\n\n\n\n\nAge, y\n78 (68, 86)\n67 (57, 76)\n67 (57, 75)\n64 (54, 72)\n62 (52, 70)\n71 (61, 80)\n78 (67, 87)\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Female\n8,425 (51%)\n144,495 (54%)\n31,365 (46%)\n28,105 (53%)\n45,480 (63%)\n12,135 (47%)\n18,985 (61%)\n\n\n\n\n    Male\n8,005 (49%)\n123,150 (46%)\n37,405 (54%)\n24,715 (47%)\n27,215 (37%)\n13,685 (53%)\n12,125 (39%)\n\n\n\n\nRace\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    White\n10,505 (66%)\n170,820 (65%)\n45,020 (67%)\n33,650 (65%)\n45,145 (64%)\n15,765 (63%)\n20,735 (68%)\n\n\n\n\n    Asian or Pacific Islander\n650 (4.1%)\n5,100 (2.0%)\n1,025 (1.5%)\n725 (1.4%)\n515 (0.7%)\n700 (2.8%)\n1,485 (4.9%)\n\n\n\n\n    Black\n2,880 (18%)\n55,815 (21%)\n12,860 (19%)\n11,335 (22%)\n18,125 (26%)\n5,015 (20%)\n5,600 (18%)\n\n\n\n\n    Hispanic\n1,485 (9.3%)\n22,095 (8.5%)\n6,245 (9.3%)\n4,550 (8.8%)\n5,155 (7.3%)\n2,870 (11%)\n1,790 (5.9%)\n\n\n\n\n    Native American\n55 (0.3%)\n1,255 (0.5%)\n320 (0.5%)\n195 (0.4%)\n470 (0.7%)\n95 (0.4%)\n120 (0.4%)\n\n\n\n\n    Other\n405 (2.5%)\n5,900 (2.3%)\n1,545 (2.3%)\n1,090 (2.1%)\n1,410 (2.0%)\n750 (3.0%)\n700 (2.3%)\n\n\n\n\nResidential income\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    $1 - $51,999\n5,115 (31%)\n87,030 (33%)\n21,100 (31%)\n17,095 (33%)\n25,685 (36%)\n8,140 (32%)\n9,895 (32%)\n\n\n\n\n    $52,000 - $65,999\n4,490 (28%)\n71,930 (27%)\n18,375 (27%)\n14,485 (28%)\n19,800 (28%)\n6,670 (26%)\n8,110 (26%)\n\n\n\n\n    $66,000 - $87,999\n3,630 (22%)\n61,345 (23%)\n16,335 (24%)\n12,340 (24%)\n16,235 (23%)\n6,155 (24%)\n6,650 (22%)\n\n\n\n\n    $88,000 or more\n3,010 (19%)\n43,660 (17%)\n12,070 (18%)\n8,195 (16%)\n9,930 (14%)\n4,495 (18%)\n5,960 (19%)\n\n\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Private\n2,220 (14%)\n76,275 (29%)\n21,625 (31%)\n18,200 (35%)\n24,105 (33%)\n6,345 (25%)\n3,780 (12%)\n\n\n\n\n    Medicaid\n1,310 (8.0%)\n31,095 (12%)\n6,920 (10%)\n6,685 (13%)\n11,105 (15%)\n2,490 (9.6%)\n2,585 (8.3%)\n\n\n\n\n    Medicare\n12,600 (77%)\n153,715 (57%)\n38,315 (56%)\n26,540 (50%)\n35,675 (49%)\n16,355 (63%)\n24,230 (78%)\n\n\n\n\n    Other\n295 (1.8%)\n6,260 (2.3%)\n1,825 (2.7%)\n1,305 (2.5%)\n1,720 (2.4%)\n620 (2.4%)\n495 (1.6%)\n\n\n\n\nHospital region\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    East North Central\n3,050 (19%)\n50,525 (19%)\n14,145 (21%)\n10,035 (19%)\n13,700 (19%)\n4,565 (18%)\n5,030 (16%)\n\n\n\n\n    East South Central\n870 (5.3%)\n21,330 (8.0%)\n5,110 (7.4%)\n4,210 (8.0%)\n6,795 (9.3%)\n1,710 (6.6%)\n2,635 (8.5%)\n\n\n\n\n    Middle Atlantic\n2,160 (13%)\n31,405 (12%)\n7,370 (11%)\n5,755 (11%)\n8,670 (12%)\n2,950 (11%)\n4,500 (14%)\n\n\n\n\n    Mountain\n790 (4.8%)\n11,805 (4.4%)\n2,910 (4.2%)\n2,415 (4.6%)\n3,210 (4.4%)\n1,175 (4.6%)\n1,305 (4.2%)\n\n\n\n\n    New England\n755 (4.6%)\n10,340 (3.9%)\n2,770 (4.0%)\n2,100 (4.0%)\n2,365 (3.3%)\n1,065 (4.1%)\n1,285 (4.1%)\n\n\n\n\n    Pacific\n2,280 (14%)\n32,930 (12%)\n8,405 (12%)\n6,785 (13%)\n7,705 (11%)\n3,375 (13%)\n4,380 (14%)\n\n\n\n\n    South Atlantic\n3,290 (20%)\n59,440 (22%)\n15,540 (23%)\n11,705 (22%)\n15,835 (22%)\n6,280 (24%)\n6,790 (22%)\n\n\n\n\n    West North Central\n1,125 (6.8%)\n17,460 (6.5%)\n4,780 (7.0%)\n3,475 (6.6%)\n4,885 (6.7%)\n1,410 (5.5%)\n1,785 (5.7%)\n\n\n\n\n    West South Central\n2,110 (13%)\n32,415 (12%)\n7,740 (11%)\n6,340 (12%)\n9,535 (13%)\n3,290 (13%)\n3,400 (11%)\n\n\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n0.3\n\n\n    Large\n8,490 (52%)\n143,670 (54%)\n37,440 (54%)\n28,100 (53%)\n39,370 (54%)\n13,745 (53%)\n16,525 (53%)\n\n\n\n\n    Medium\n4,775 (29%)\n74,800 (28%)\n18,840 (27%)\n15,070 (29%)\n20,210 (28%)\n7,310 (28%)\n8,595 (28%)\n\n\n\n\n    Small\n3,165 (19%)\n49,180 (18%)\n12,490 (18%)\n9,650 (18%)\n13,120 (18%)\n4,765 (18%)\n5,990 (19%)\n\n\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Rural\n1,000 (6.1%)\n16,735 (6.3%)\n3,870 (5.6%)\n3,330 (6.3%)\n4,885 (6.7%)\n1,375 (5.3%)\n2,275 (7.3%)\n\n\n\n\n    Urban, non-teaching\n2,985 (18%)\n47,040 (18%)\n12,265 (18%)\n9,395 (18%)\n12,195 (17%)\n4,765 (18%)\n5,435 (17%)\n\n\n\n\n    Urban, teaching\n12,445 (76%)\n203,875 (76%)\n52,635 (77%)\n40,095 (76%)\n55,620 (77%)\n19,680 (76%)\n23,400 (75%)\n\n\n\n\nHypertension\n13,595 (83%)\n233,375 (87%)\n61,555 (90%)\n47,200 (89%)\n64,340 (89%)\n22,570 (87%)\n24,115 (78%)\n&lt;0.001\n\n\nDiabetes mellitus\n5,405 (33%)\n132,175 (49%)\n35,800 (52%)\n29,585 (56%)\n42,770 (59%)\n12,130 (47%)\n6,485 (21%)\n&lt;0.001\n\n\nHyperlipidemia\n8,770 (53%)\n172,785 (65%)\n49,065 (71%)\n36,710 (70%)\n46,880 (64%)\n16,910 (65%)\n14,450 (46%)\n&lt;0.001\n\n\nPeripheral vascular disease\n1,860 (11%)\n22,695 (8.5%)\n5,790 (8.4%)\n4,090 (7.7%)\n4,485 (6.2%)\n2,470 (9.6%)\n4,000 (13%)\n&lt;0.001\n\n\nCoronary artery disease\n3,955 (24%)\n60,415 (23%)\n16,610 (24%)\n11,860 (22%)\n14,950 (21%)\n6,250 (24%)\n6,790 (22%)\n&lt;0.001\n\n\nHeart failure\n3,780 (23%)\n57,490 (21%)\n12,465 (18%)\n10,350 (20%)\n18,395 (25%)\n4,940 (19%)\n7,560 (24%)\n&lt;0.001\n\n\nCOPD\n2,710 (16%)\n51,880 (19%)\n10,795 (16%)\n9,385 (18%)\n16,575 (23%)\n4,075 (16%)\n8,340 (27%)\n&lt;0.001\n\n\nChronic kidney disease\n3,690 (22%)\n53,570 (20%)\n13,230 (19%)\n10,085 (19%)\n15,160 (21%)\n5,440 (21%)\n5,965 (19%)\n&lt;0.001\n\n\nValvular Heart Disease\n2,115 (13%)\n24,015 (9.0%)\n6,090 (8.9%)\n4,020 (7.6%)\n5,210 (7.2%)\n2,810 (11%)\n3,770 (12%)\n&lt;0.001\n\n\nLiver Disease\n505 (3.1%)\n6,400 (2.4%)\n1,465 (2.1%)\n1,055 (2.0%)\n1,725 (2.4%)\n690 (2.7%)\n960 (3.1%)\n&lt;0.001\n\n\nAtrial Fibrillation\n4,220 (26%)\n53,975 (20%)\n12,645 (18%)\n9,125 (17%)\n14,665 (20%)\n5,360 (21%)\n7,960 (26%)\n&lt;0.001\n\n\nCancer\n1,075 (6.5%)\n7,495 (2.8%)\n1,545 (2.2%)\n1,005 (1.9%)\n1,160 (1.6%)\n915 (3.5%)\n1,795 (5.8%)\n&lt;0.001\n\n\nDementia\n4,040 (25%)\n22,640 (8.5%)\n3,830 (5.6%)\n2,140 (4.1%)\n1,910 (2.6%)\n3,000 (12%)\n7,720 (25%)\n&lt;0.001\n\n\nCharlson comorbidity index\n4.00 (3.00, 6.00)\n4.00 (3.00, 5.00)\n4.00 (2.00, 5.00)\n4.00 (2.00, 5.00)\n4.00 (3.00, 5.00)\n4.00 (3.00, 5.00)\n4.00 (3.00, 6.00)\n&lt;0.001\n\n\nPrior MI\n1,195 (7.3%)\n19,485 (7.3%)\n5,495 (8.0%)\n4,080 (7.7%)\n4,775 (6.6%)\n1,915 (7.4%)\n2,025 (6.5%)\n&lt;0.001\n\n\nPrior PCI\n955 (5.8%)\n16,920 (6.3%)\n5,220 (7.6%)\n3,725 (7.1%)\n3,885 (5.3%)\n1,835 (7.1%)\n1,300 (4.2%)\n&lt;0.001\n\n\nPrior CABG\n990 (6.0%)\n13,045 (4.9%)\n4,120 (6.0%)\n2,635 (5.0%)\n2,510 (3.5%)\n1,575 (6.1%)\n1,215 (3.9%)\n&lt;0.001\n\n\nTobbacco use disorder\n145 (0.9%)\n2,450 (0.9%)\n700 (1.0%)\n510 (1.0%)\n585 (0.8%)\n240 (0.9%)\n270 (0.9%)\n0.6\n\n\nAlcohol Abuse\n5,350 (33%)\n86,170 (32%)\n22,845 (33%)\n16,385 (31%)\n22,555 (31%)\n8,505 (33%)\n10,530 (34%)\n&lt;0.001\n\n\nIV tissue-type plasminogen activator\n1,475 (9.0%)\n34,865 (13%)\n9,265 (13%)\n7,505 (14%)\n10,680 (15%)\n3,370 (13%)\n2,570 (8.3%)\n&lt;0.001\n\n\nThrombectomy\n715 (4.4%)\n12,845 (4.8%)\n3,255 (4.7%)\n2,395 (4.5%)\n3,910 (5.4%)\n1,230 (4.8%)\n1,340 (4.3%)\n0.005\n\n\n\n1 Median (Q1, Q3); n (%)\n\n\n2 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment"
  },
  {
    "objectID": "quarto/index.html#outcomes-table",
    "href": "quarto/index.html#outcomes-table",
    "title": "Impact of Body Mass Index on Hospitalization Outcomes in Patients With Acute Ischemic Stroke",
    "section": "Outcomes Table:",
    "text": "Outcomes Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nNormal weight (BMI 20.0-24.9kg/m²) N = 16,4301\nOverall N = 267,6501\nClass I obesity (BMI 30.0-34.9kg/m²) N = 68,7701\nClass II obesity (BMI 35.0-39.9kg/m²) N = 52,8201\nClass III obesity (BMI ≥40.0kg/m²) N = 72,7001\nOverweight (BMI 25.0-29.9kg/m²) N = 25,8201\nUnderweight (BMI ≤19.9kg/m²) N = 31,1101\np-value2\n\n\n\n\nDied during hospitalization\n925 (5.6%)\n8,495 (3.2%)\n1,380 (2.0%)\n1,110 (2.1%)\n2,115 (2.9%)\n770 (3.0%)\n2,195 (7.1%)\n&lt;0.001\n\n\nLength of stay (days)\n5.0 (3.0, 9.0)\n4.0 (2.0, 6.0)\n3.0 (2.0, 6.0)\n3.0 (2.0, 6.0)\n4.0 (2.0, 6.0)\n4.0 (2.0, 7.0)\n5.0 (3.0, 9.0)\n&lt;0.001\n\n\nInflation-adjusted total charge ($)\n58,790 (33,838, 107,794)\n48,685 (28,576, 88,709)\n45,731 (27,137, 82,839)\n45,642 (27,481, 81,700)\n48,046 (28,618, 87,611)\n53,344 (29,646, 98,523)\n53,886 (31,443, 100,114)\n&lt;0.001\n\n\n\n1 n (%); Median (Q1, Q3)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test"
  },
  {
    "objectID": "quarto/index.html#multivariable-logistic-regression",
    "href": "quarto/index.html#multivariable-logistic-regression",
    "title": "Impact of Body Mass Index on Hospitalization Outcomes in Patients With Acute Ischemic Stroke",
    "section": "Multivariable Logistic Regression:",
    "text": "Multivariable Logistic Regression:\n\nAll-Cause Mortality:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR1\n95% CI1\np-value\n\n\n\n\nBMI\n\n\n\n\n\n\n\n\n    Normal weight (BMI 20.0-24.9kg/m²)\n—\n—\n\n\n\n\n    Class I obesity (BMI 30.0-34.9kg/m²)\n0.51\n0.41, 0.63\n&lt;0.001\n\n\n    Class II obesity (BMI 35.0-39.9kg/m²)\n0.56\n0.45, 0.71\n&lt;0.001\n\n\n    Class III obesity (BMI ≥40.0kg/m²)\n0.74\n0.60, 0.92\n0.006\n\n\n    Overweight (BMI 25.0-29.9kg/m²)\n0.67\n0.53, 0.85\n&lt;0.001\n\n\n    Underweight (BMI ≤19.9kg/m²)\n1.20\n0.99, 1.45\n0.065\n\n\nAge, y\n1.02\n1.02, 1.03\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.23\n1.10, 1.36\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.21\n0.88, 1.65\n0.2\n\n\n    Black\n0.94\n0.81, 1.09\n0.4\n\n\n    Hispanic\n0.91\n0.74, 1.12\n0.4\n\n\n    Native American\n0.63\n0.26, 1.51\n0.3\n\n\n    Other\n1.10\n0.79, 1.52\n0.6\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.90\n0.79, 1.03\n0.13\n\n\n    $66,000 - $87,999\n0.86\n0.74, 1.00\n0.048\n\n\n    $88,000 or more\n0.88\n0.75, 1.04\n0.15\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.99\n0.80, 1.22\n&gt;0.9\n\n\n    Medicare\n0.98\n0.84, 1.15\n0.8\n\n\n    Other\n1.32\n0.93, 1.89\n0.12\n\n\nHospital region\n\n\n\n\n\n\n\n\n    East North Central\n—\n—\n\n\n\n\n    East South Central\n1.01\n0.79, 1.29\n&gt;0.9\n\n\n    Middle Atlantic\n0.96\n0.78, 1.17\n0.7\n\n\n    Mountain\n0.90\n0.67, 1.21\n0.5\n\n\n    New England\n1.15\n0.88, 1.49\n0.3\n\n\n    Pacific\n1.31\n1.08, 1.58\n0.005\n\n\n    South Atlantic\n0.88\n0.74, 1.05\n0.2\n\n\n    West North Central\n0.74\n0.57, 0.96\n0.025\n\n\n    West South Central\n0.99\n0.81, 1.22\n&gt;0.9\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.84\n0.74, 0.95\n0.008\n\n\n    Small\n0.68\n0.57, 0.79\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.81\n0.62, 1.06\n0.12\n\n\n    Urban, teaching\n1.14\n0.91, 1.43\n0.2\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.68\n0.59, 0.78\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.86\n0.75, 0.97\n0.014\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.57\n0.51, 0.64\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.16\n1.00, 1.34\n0.046\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.89\n0.74, 1.06\n0.2\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.47\n1.30, 1.66\n&lt;0.001\n\n\nCOPD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.85\n0.75, 0.97\n0.018\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.80\n0.70, 0.93\n0.003\n\n\nValvular Heart Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.77\n0.65, 0.92\n0.004\n\n\nLiver Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.60\n1.23, 2.08\n&lt;0.001\n\n\nAtrial Fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.37\n1.21, 1.54\n&lt;0.001\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.89\n0.69, 1.15\n0.4\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.83\n0.71, 0.99\n0.034\n\n\nCharlson comorbidity index\n1.17\n1.14, 1.21\n&lt;0.001\n\n\nPrior MI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.64\n0.51, 0.81\n&lt;0.001\n\n\nPrior PCI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.72\n0.56, 0.94\n0.014\n\n\nPrior CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.77\n0.59, 1.01\n0.060\n\n\nTobbacco use disorder\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.94\n0.51, 1.71\n0.8\n\n\nAlcohol Abuse\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.93\n0.83, 1.05\n0.3\n\n\nIV tissue-type plasminogen activator\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.04\n0.90, 1.21\n0.6\n\n\nThrombectomy\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.68\n2.25, 3.19\n&lt;0.001\n\n\n\n1 OR = Odds Ratio, CI = Confidence Interval"
  },
  {
    "objectID": "quarto/index.html#multivariable-linear-regression",
    "href": "quarto/index.html#multivariable-linear-regression",
    "title": "Impact of Body Mass Index on Hospitalization Outcomes in Patients With Acute Ischemic Stroke",
    "section": "Multivariable Linear Regression:",
    "text": "Multivariable Linear Regression:\n\nLength of Stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI1\np-value\n\n\n\n\nBMI\n\n\n\n\n\n\n\n\n    Normal weight (BMI 20.0-24.9kg/m²)\n—\n—\n\n\n\n\n    Class I obesity (BMI 30.0-34.9kg/m²)\n-2.4\n-2.7, -2.1\n&lt;0.001\n\n\n    Class II obesity (BMI 35.0-39.9kg/m²)\n-2.4\n-2.8, -2.1\n&lt;0.001\n\n\n    Class III obesity (BMI ≥40.0kg/m²)\n-2.0\n-2.3, -1.7\n&lt;0.001\n\n\n    Overweight (BMI 25.0-29.9kg/m²)\n-1.4\n-1.8, -1.0\n&lt;0.001\n\n\n    Underweight (BMI ≤19.9kg/m²)\n-0.36\n-0.72, 0.01\n0.053\n\n\nAge, y\n0.00\n-0.01, 0.01\n0.9\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.29\n0.17, 0.42\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.83\n0.29, 1.4\n0.003\n\n\n    Black\n0.81\n0.63, 0.99\n&lt;0.001\n\n\n    Hispanic\n0.30\n0.05, 0.54\n0.017\n\n\n    Native American\n-0.43\n-1.2, 0.31\n0.3\n\n\n    Other\n1.1\n0.51, 1.7\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-0.20\n-0.37, -0.04\n0.015\n\n\n    $66,000 - $87,999\n-0.25\n-0.43, -0.08\n0.004\n\n\n    $88,000 or more\n-0.45\n-0.65, -0.24\n&lt;0.001\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.7\n1.4, 2.1\n&lt;0.001\n\n\n    Medicare\n0.10\n-0.07, 0.27\n0.3\n\n\n    Other\n0.32\n-0.06, 0.70\n0.10\n\n\nHospital region\n\n\n\n\n\n\n\n\n    East North Central\n—\n—\n\n\n\n\n    East South Central\n0.10\n-0.23, 0.43\n0.5\n\n\n    Middle Atlantic\n0.49\n0.24, 0.75\n&lt;0.001\n\n\n    Mountain\n-0.29\n-0.60, 0.03\n0.072\n\n\n    New England\n0.25\n-0.14, 0.63\n0.2\n\n\n    Pacific\n-0.38\n-0.64, -0.13\n0.003\n\n\n    South Atlantic\n0.56\n0.33, 0.79\n&lt;0.001\n\n\n    West North Central\n-0.40\n-0.64, -0.16\n0.001\n\n\n    West South Central\n0.18\n-0.07, 0.42\n0.2\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-0.74\n-0.91, -0.57\n&lt;0.001\n\n\n    Small\n-1.3\n-1.4, -1.1\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.57\n0.32, 0.83\n&lt;0.001\n\n\n    Urban, teaching\n1.5\n1.2, 1.7\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.57\n-0.80, -0.34\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.20\n-0.34, -0.05\n0.007\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.76\n-0.90, -0.62\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.10\n-0.08, 0.28\n0.3\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.31\n-0.52, -0.09\n0.005\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.88\n0.71, 1.1\n&lt;0.001\n\n\nCOPD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.52\n-0.67, -0.38\n&lt;0.001\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.45\n-0.65, -0.26\n&lt;0.001\n\n\nValvular Heart Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.15\n-0.06, 0.36\n0.2\n\n\nLiver Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.55\n0.07, 1.0\n0.024\n\n\nAtrial Fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.42\n0.26, 0.57\n&lt;0.001\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.44\n-0.79, -0.09\n0.014\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.68\n0.42, 0.94\n&lt;0.001\n\n\nCharlson comorbidity index\n0.40\n0.35, 0.44\n&lt;0.001\n\n\nPrior MI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.87\n-1.1, -0.65\n&lt;0.001\n\n\nPrior PCI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.48\n-0.69, -0.26\n&lt;0.001\n\n\nPrior CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.43\n-0.64, -0.21\n&lt;0.001\n\n\nTobbacco use disorder\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.33\n-0.51, 1.2\n0.4\n\n\nAlcohol Abuse\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.25\n0.09, 0.40\n0.002\n\n\nIV tissue-type plasminogen activator\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.33\n-0.49, -0.17\n&lt;0.001\n\n\nThrombectomy\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n3.2\n2.8, 3.6\n&lt;0.001\n\n\n\n1 CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nInflation Adjusted Total Charge:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI1\np-value\n\n\n\n\nBMI\n\n\n\n\n\n\n\n\n    Normal weight (BMI 20.0-24.9kg/m²)\n—\n—\n\n\n\n\n    Class I obesity (BMI 30.0-34.9kg/m²)\n-21,429\n-25,370, -17,489\n&lt;0.001\n\n\n    Class II obesity (BMI 35.0-39.9kg/m²)\n-23,013\n-27,071, -18,956\n&lt;0.001\n\n\n    Class III obesity (BMI ≥40.0kg/m²)\n-17,983\n-22,219, -13,747\n&lt;0.001\n\n\n    Overweight (BMI 25.0-29.9kg/m²)\n-9,227\n-13,962, -4,492\n&lt;0.001\n\n\n    Underweight (BMI ≤19.9kg/m²)\n-5,095\n-9,482, -707\n0.023\n\n\nAge, y\n-364\n-458, -270\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n4,208\n2,445, 5,970\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n12,630\n4,444, 20,816\n0.003\n\n\n    Black\n5,183\n2,503, 7,863\n&lt;0.001\n\n\n    Hispanic\n19,514\n14,273, 24,755\n&lt;0.001\n\n\n    Native American\n-21,870\n-29,157, -14,582\n&lt;0.001\n\n\n    Other\n24,574\n15,941, 33,206\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-2,441\n-5,020, 138\n0.064\n\n\n    $66,000 - $87,999\n-3,096\n-5,858, -335\n0.028\n\n\n    $88,000 or more\n-2,225\n-5,800, 1,351\n0.2\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n13,630\n9,715, 17,545\n&lt;0.001\n\n\n    Medicare\n4,714\n2,344, 7,084\n&lt;0.001\n\n\n    Other\n3,725\n-2,911, 10,360\n0.3\n\n\nHospital region\n\n\n\n\n\n\n\n\n    East North Central\n—\n—\n\n\n\n\n    East South Central\n4,095\n-958, 9,148\n0.11\n\n\n    Middle Atlantic\n30,469\n25,024, 35,915\n&lt;0.001\n\n\n    Mountain\n27,042\n19,108, 34,975\n&lt;0.001\n\n\n    New England\n-7,078\n-12,340, -1,816\n0.008\n\n\n    Pacific\n33,463\n28,061, 38,865\n&lt;0.001\n\n\n    South Atlantic\n13,098\n9,452, 16,743\n&lt;0.001\n\n\n    West North Central\n-1,846\n-5,465, 1,773\n0.3\n\n\n    West South Central\n20,885\n15,663, 26,107\n&lt;0.001\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-5,900\n-9,439, -2,360\n0.001\n\n\n    Small\n-14,656\n-17,709, -11,603\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n22,745\n19,191, 26,299\n&lt;0.001\n\n\n    Urban, teaching\n29,576\n26,929, 32,223\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-8,911\n-12,400, -5,422\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-2,046\n-4,125, 33\n0.054\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-6,777\n-8,689, -4,864\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n3,495\n1,169, 5,821\n0.003\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1,544\n-4,613, 1,526\n0.3\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n11,347\n8,653, 14,041\n&lt;0.001\n\n\nCOPD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-4,162\n-6,259, -2,065\n&lt;0.001\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-6,899\n-9,457, -4,341\n&lt;0.001\n\n\nValvular Heart Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1,659\n-4,309, 990\n0.2\n\n\nLiver Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n12,560\n1,668, 23,452\n0.024\n\n\nAtrial Fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n5,962\n3,813, 8,110\n&lt;0.001\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1,768\n-6,551, 3,015\n0.5\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-4,793\n-7,400, -2,186\n&lt;0.001\n\n\nCharlson comorbidity index\n3,941\n3,314, 4,567\n&lt;0.001\n\n\nPrior MI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-13,215\n-16,043, -10,388\n&lt;0.001\n\n\nPrior PCI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-5,784\n-8,711, -2,857\n&lt;0.001\n\n\nPrior CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-3,839\n-7,195, -484\n0.025\n\n\nTobbacco use disorder\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-491\n-9,038, 8,055\n&gt;0.9\n\n\nAlcohol Abuse\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n4,838\n1,567, 8,108\n0.004\n\n\nIV tissue-type plasminogen activator\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n32,746\n29,771, 35,721\n&lt;0.001\n\n\nThrombectomy\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n129,795\n120,074, 139,516\n&lt;0.001\n\n\n\n1 CI = Confidence Interval"
  }
]